Effectiveness of Myopia Control Interventions : A Comparison of Myopia Control in European Children, Adolescents and Young Adults With Defocus Incorporated Multiple Segments (DIMS) and Highly Aspherical Lenslets (HAL) Spectacles, Atropine, Lenses and Combined Treatments

Centre Hospitalier Universitaire de Saint Etienne

Status: Completed

Conditions: Myopia

Treatments: Other: Potential adverse events; Other: Ophthalmological data at each examination; Other: Demographic data collection; Other: Ophthalmological history

Study type: Observational

Funder types: Other

Identifiers

NCT07120165

IRBN1022025/CHUSTE

Details and patient eligibility

About

The prevalence of myopia and its complications has risen considerably in recent decades, particularly among children and teenagers. This trend is also spreading in Europe, driven by the increase in screen time and the intensive use of new technologies and social media, particularly among the younger generation.

Several treatment options are available today, including pharmacological treatments with atropine eye drops, as well as optical myopia control systems in the form of glasses or contact lenses.

These different treatments have been used in clinical practice at Saint-Étienne University Hospital since 2017 for atropine, and more recently with the development of optical myopia control systems and their combinations.

Little clinical data has been published to date on these different treatment combinations in the French population.

The investigators would therefore like to set up a database to publish their results and share their experience.

Enrollment: 114 patients

Sex: All

Ages: Under 25 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children or young adults with active myopia treated with ATROPINE 0.01% eye drops or myopia control glasses or contact lenses, and their various combinations
• patient affiliated with a social security organization
• agreement of both parents or the patient if adult

Exclusion criteria

• non compliance with treatment

Trial design

114 participants in 3 patient groups

Atropine 0.01%

Description:

Children or young adults with active myopia treated with ATROPINE 0.01% eye drops.

Treatment:

Other: Ophthalmological history

Other: Demographic data collection

Other: Ophthalmological data at each examination

Other: Potential adverse events

DIMS/HAL

Description:

Children or young adults with active myopia treated with myopia control glasses.

Treatment:

Other: Ophthalmological history

Other: Demographic data collection

Other: Ophthalmological data at each examination

Other: Potential adverse events

Various combined treatments

Description:

Children or young adults with active myopia treated with ATROPINE 0.01% eye drops or myopia control glasses or contact lenses, and their various combinations.

Treatment:

Other: Ophthalmological history

Other: Demographic data collection

Other: Ophthalmological data at each examination

Other: Potential adverse events